natgillin/translations-raw huggingface dataset:
If the top of the plunger has been pushed past the line, you should continue from step 4d and take the injection.
Če je bil vrh bata pritisnjen preko črte, nadaljujte s korakom 4d in dajte injekcijo.
Refer to the package leaflet (section 3) on what to do if you are not sure if you have received a complete dose.
Glejte Navodilo za uporabo (poglavje 3), kaj narediti v primeru, če niste prepričani, ali ste prejeli celotni odmerek.
Read and follow each step in these instructions carefully every time you take Bydureon.
Previdno preberite in sledite vsakemu koraku teh navodil vsakokrat, ko vzamete zdravilo Bydureon.
You should see your doctor immediately if you experience symptoms such as
Takoj se obrnite na zdravnika, če imate simptome kot so:
In the event of overdose, appropriate supportive treatment should be initiated according to the patient's clinical signs and symptoms.
V primeru prevelikega odmerjanja je potrebno začeti z ustreznim podpornim zdravljenjem glede na bolnikove klinične znake in simptome.
• Bydureon BCise pen should not be used by people who are blind or cannot see well, unless another person who is trained to use this device can help.
• Peresnika Bydureon BCise ne smejo uporabljati slepe ali slabovidne osebe, razen če jim lahko pomaga druga oseba, usposobljena za uporabo tega pripomočka.
You may see or feel a small bump under the skin after your injection; it should go away after 4 to 8 weeks.
Po injiciranju boste morda opazili ali čutili pod kožo majhno bulo; le ta bo izginila v 4 do 8 tednih.
Months from Randomization
Meseci od randomizacije
I am having trouble mixing my dose.
Imam težave z mešanjem odmerka.
If not mixed well, repeat Step 2 and check again.
Če zdravilo ni dobro premešano, ponovite 2. korak in znova preverite.
- How to inject this medicine.
- Kako injicirati to zdravilo.
The overall incidence of minor hypoglycaemia was 6.3%.
Celotna Incidenca blagih hipoglikemij je bila 6,3 %.
The black dashed Dose Line shows the correct dose.
Črna odmerna črta kaže pravilni odmerek.
• Remove the needle cover and give the injection, see steps 4e to 4g
• odstraniti pokrovček igle in dati injekcijo, glejte korake 4e do 4g
The mean apparent clearance of exenatide is 9 l/h.
Povprečni navidezni očistek eksenatida je 9 l/h.
Your guide to the parts
Vaš vodič do sestavnih delov
You will not need the cap and can throw it away.
Pokrovčka ne boste potrebovali, zato ga lahko zavržete.
You should not need to stop your treatment.
Zdravljenja ni potrebno prekiniti.
DO NOT use your pen or needle if any parts are broken or missing.
NE UPORABITE peresnika ali igle, če je kakšen del zlomljen ali manjka.
• Tell your doctor if you have had pancreatitis, gallstones, alcoholism or very high triglycerides.
• Povejte zdravniku, če ste kdaj imeli pankreatitis, žolčne kamne, alkoholizem ali zelo visoko raven trigliceridov.
Gender, race and body weight Gender, race and body weight have no clinically relevant influence on exenatide pharmacokinetics.
Spol, rasa in telesna masa Spol, rasa in telesna masa nimajo klinično pomembnega vpliva na farmakokinetiko eksenatida.
Locked Position
Zaklenjen položaj
A container is not included in the carton.
Vsebnik ni priložen v škatli.
The active substance in this medicine slows stomach emptying so food passes more slowly through your stomach.
Učinkovina v tem zdravilu upočasni praznjenje želodca, tako da hrana počasneje potuje skozi vaš želodec.
The 156-week results were consistent with those previously reported in the 26-week interim report.
Rezultati po 156 tednih so bili skladni s tistimi, ki so bili predhodno poročani v vmesnem poročilu po 26 tednih.
This is how the parts should now look when they are connected.
Tako morajo izgledati sestavni deli, ko jih povežete skupaj.
In most patients who develop antibodies, antibody titres diminish over time.
Pri večini bolnikov, ki razvijejo protitelesa, se titri protiteles s časom zmanjšajo.
• Swelling of the face, tongue or throat (angioedema)
• oteklost obraza, jezika ali žrela (angiodem)
These medical conditions can increase the risk of getting pancreatitis, or getting it again, whether or not you are taking this medicine.
Ta zdravstvena stanja namreč povečujejo tveganje, da dobite (ali ponovno dobite) pankreatitis, ne glede na to, ali uporabljate to zdravilo ali ne.
You may give both injections in the same body area (for example, your stomach area), but you should not give the injections next to each other.
Obe injekciji lahko daste v isti predel telesa (npr. v predel trebuha), vendar pa ju ne smete dati ene zraven druge.
The medicine should look even throughout (see pictures in Figure G and Figure H, Step 2C).
Zdravilo mora biti popolnoma enakomernega videza (glejte prikaza na sliki G in H, korak 2C).
Supplies needed to give your injection:
Oprema, ki jo potrebujete za injiciranje:
Overall, 26.9% of patients did not have any prior CV event, 73.1% had at least one prior CV event.
V celoti ni imelo 26,9 % bolnikov nobenega predhodnega SŽ dogodka, 73,1 % pa jih je imelo vsaj en predhoden SŽ dogodek.
At the end of this period the pens must be used or discarded.
Po preteku tega obdobja je potrebno peresnik uporabiti ali zavreči.
Each single-dose kit has everything you need for your weekly dose of Bydureon.
Vsak enoodmerni set vsebuje vse, kar potrebujete za vaš tedenski odmerek zdravila Bydureon.
Look
Poglejte
C. Check the suspension.
C. Suspenzijo preglejte.
• dehydration, sometimes with a decrease in kidney function
• dehidracija, včasih z zmanjšanjem delovanja ledvic
B. Check the expiration date (labelled EXP) printed on the pen label.
B. Preverite datum izteka roka uporabnosti (označen je z EXP), ki je natisnjen na nalepki peresnika.
This medicine helps your body to increase the production of insulin when your blood sugar is high.
To zdravilo vašemu telesu pomaga povečati proizvodnjo insulina, kadar je vaš sladkor v krvi visok.
Your doctor should tell you how to treat low blood sugar.
Zdravnik naj vam pove, kako zdraviti nizek sladkor v krvi.
INSTRUCTIONS FOR THE USER
NAVODILA ZA UPORABNIKA
This medicine should be discontinued at least 3 months before a planned pregnancy.
Zdravljenje s tem zdravilom je treba prekiniti vsaj tri mesece pred načrtovano nosečnostjo.
It is important to stop pushing at this point, or you will waste your medicine and you will not get the correct dose.
Sedaj je pomembno, da nehate pritiskati, saj boste sicer zavrgli vaše zdravilo in ne boste prejeli pravilnega odmerka.
All-cause mortality was the initial secondary endpoint assessed.
Umrljivost zaradi vseh vzrokov je bila uvodni ocenjevani sekundarni opazovani dogodek.
A. Look in the window.
A. Poglejte okence.
Do not take two doses of Bydureon within 3 days of each other.
Ne uporabite dveh odmerkov zdravila Bydureon v presledku manj kot 3 dni.
Patients were followed as in routine clinical practice for a median of 38.7 months with a median treatment duration of 27.8 months.
Bolnike so nato spremljali tako kot v redni klinični praksi, in sicer mediano 38,7 meseca in z medianim trajanjem zdravljenja 27,8 meseca.
Bydureon only needs to be taken once a week.
Zdravilo Bydureon je potrebno vzeti le enkrat na teden.
The presence of antibodies (high or low titres) is not predictive of glycaemic control for an individual patient.
Prisotnost protiteles (visoki in nizki titri) ne napove glikemične kontrole pri posameznih bolnikih.
You will feel the needle go into your skin.
Čutili boste iglo, ki bo šla v kožo.
After removing the connector be careful not to push in the plunger.
Po odstranitvi povezovalca bodite previdni, da ne pritisnete na bat.
The mean age at study entry was 62 years (with 8.5% of the patients ≥75 years).
Povprečna starost ob vstopu v študijo je bila 62 let (8,5 % bolnikov je bilo starih ≥ 75 let).
• Do not use the pen if any parts look to be broken or damaged.
• Peresnika ne uporabite, če je kakšen njegov del videti zlomljen ali poškodovan.
See question number:
Glejte vprašanje pod številko:
Shake for at least 15 seconds.
Pretresajte vsaj 15 sekund.
For study results with respect to combinations, effects on glycaemic control and cardiovascular events, and the populations studied, see sections 4.4, 4.5, and 5.1.
Za rezultate študij glede kombinacij, učinkov na urejenost glikemije, srčno-žilne dogodke in proučevano populacijo glejte poglavja 4.4, 4.5 in 5.1.
Patients with rapid weight loss should be monitored for signs and symptoms of cholelithiasis.
Bolnike, ki hitro izgubljajo telesno maso, je treba spremljati glede znakov in simptomov holelitiaze.
What if the device malfunctions and I cannot unlock it?
Kaj, če pripomoček ne deluje pravilno in ga ne morem odkleniti?
Why do I need to hold the pen upright while removing the orange cap?
Zakaj moram držati peresnik pokonci, medtem ko odstranjujem oranžni pokrovček?
Frequencies are defined as: very common (≥ 1/10), common (≥ 1/100 to  1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1000), very rare (< 1/10,000) and not known (cannot be estimated from the available data).
Pogostnosti so opredeljene kot: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do  1/10), občasni ( 1/1.000 do < 1/100), redki ( 1/10.000 do < 1/1.000), zelo redki (< 1/10.000) in neznana pogostnost (ni mogoče oceniti iz razpoložljivih podatkov).
Hold for 10 seconds to make sure you get the full dose.
Držite 10 sekund in tako poskrbite, da boste dobili celoten odmerek.
Patients may be treated to relieve symptoms, while continuing treatment.
Bolnikove simptome se lahko blaži ob nadaljevanju zdravljenja.
With one hand, hold the plunger in place so it does not move.
Z eno roko držite bat tako, da se ne bo premikal.
Use of GLP-1 receptor agonists has been associated with a risk of developing acute pancreatitis.
Uporabo agonistov za GLP-1 receptorje povezujejo s tveganjem za razvoj akutnega pankreatitisa.
• Remove the blue cap of the needle, see step 1d
• odstraniti moder pokrovček igli, glejte korak 1d
Discontinuation of treatment
Ukinitev zdravljenja
Thereafter, patients can resume their usual once weekly dosing schedule.
Potem lahko bolnik nadaljuje uporabo po običajnemu urniku enkrat na teden.
Most individual nodules were asymptomatic, did not interfere with study participation and resolved over 4 to 8 weeks.
Večina nodulov je bila asimptomatska, ni vplivala na udeležbo v študiji in je izzvenela v 4 do 8 tednih.
p-values are all adjusted p-values for multiplicity.
Vse vrednosti p so vrednosti p, prilagojene za večkratno testiranje.
See the Common Questions & Answers for what to do if you do not see the orange rod in the window after injection.
Glejte Pogosta vprašanja in odgovore, da boste izvedeli, kaj storiti, če po injiciranju v okencu ne vidite oranžne paličice.
With your other hand, firmly hold the 2 grey squares on the white cap.
Z drugo roko močno primite dva siva kvadrata na belem pokrovčku.
It may also help to tap the mixing window on both sides against your palm.
Pomaga lahko tudi, da z obema stranema okenca za mešanje potrkate ob dlan.
• Hypersensitivity (rashes, itching and rapid swelling of the tissues of the neck, face, mouth or throat)
• preobčutljivost (izpuščaji, srbenje in hitro otekanje tkiv v vratu, na obrazu, v ustih ali v žrelu)
You will need a puncture-resistant container that:
Potrebovali boste vsebnik, odporen proti prebadanju, ki:
The mean BMI was 32.7 kg/m2 and the mean duration of diabetes was 13.1 years.
Povprečni ITM je bil 32,7 kg/m2 in povprečno trajanje sladkorne bolezni 13,1 leta.
Do not worry that the vial might come off.
Ne skrbite, da bi se viala snela.
Choice of other medicinal products and dose selection should be considered accordingly, as adverse reactions may continue and efficacy may, at least partly, persist until exenatide levels decline.
To je potrebno upoštevati pri izboru drugih zdravil in odmerkov, saj se lahko neželeni učinki nadaljujejo in učinkovitost se lahko vsaj delno ohranja do padca koncentracije eksenatida.
If it's not mixed well, tap longer and more firmly.
Če ni dobro premešano, trkajte dalj časa in odločneje.
The percentage of these subjects with positive antibody titres, in particular high titres, peaked at approximately weeks 8 to 16 of dosing and then diminished over time.
Odstotek preiskovancev s pozitivnimi titri protiteles, zlasti visokimi titri, je dosegel vrh po približno 8 do 16 tednih uporabe in se je nato sčasoma zmanjšal.
Once absorbed into the circulation, exenatide is distributed and eliminated according to its known systemic pharmacokinetic properties (as described in this section).
Ko se eksenatid absorbira v krvožilni sistem, se porazdeli in izloči skladno z znanimi sistemskimi farmakokinetičnimi lastnostmi (kot je opisano v tem poglavju).
Lift here for a closer look at the parts
Dvignite tukaj za podroben ogled sestavnih delov
With continued therapy, the frequency decreased in most patients who initially experienced nausea.
Z nadaljevanjem zdravljenja se je pogostnost pri večini bolnikov, ki so na začetku občutili navzeo, zmanjšala.
It should be injected into the skin and not into a vein or into the muscle.
Zdravilo je treba injicirati v kožo in ne v veno ali v mišico.
• Keep the pen clean and away from spills.
• Peresnik ohranjajte čist in hranite proč od razlitij.
You have diabetes because your body does not make enough insulin to control the level of sugar in your blood or your body is not able to use the insulin properly.
Sladkorno bolezen imate, ker vaše telo ne proizvede zadosti insulina za nadzor ravni sladkorja v vaši krvi ali ker vaše telo ne more pravilno uporabiti insulina.
The plunger may feel like it is springing back a little.
Morda boste čutili, da se bat pomika malenkost nazaj.
Test your blood glucose levels regularly.
Redno testirajte nivo glukoze v krvi.
The 28-week comparator-controlled period of the study was followed by a 24-week extension period during which all participating subjects received treatment with this medicinal product.
28-tedenskemu obdobju študije, kontroliranem s primerjalno učinkovino, je sledilo 24-tedensko obdobje podaljšanja, v katerem so bili vsi sodelujoči zdravljeni s tem zdravilom.
Never mix insulin and Bydureon together in the same injection.
Insulina in zdravila Bydureon nikoli ne mešajte v isti injekcijski brizgi.
Includes follow-up within seventy days of the last dose received and extension period.
Vključeno je spremljanje sedemdeset dni po zadnjem prejetem odmerku in obdobje podaljšanja študije.
• Hives and difficulty with breathing
• koprivnica in težave z dihanjem
Resolution of pancreatitis has been observed with supportive treatment, but very rare cases of necrotising or haemorrhagic pancreatitis and/or death have been reported.
Ob podpornem zdravljenju so opažali izboljšanje pankreatitisa, vendar so opisani tudi zelo redki primeri nekrotizirajočega ali hemoragičnega pankreatitisa in/ali smrt.
Why should I store my pen flat in the refrigerator?
Zakaj moram peresnik v hladilniku shranjevati v vodoravnem položaju?
The results of the primary composite and secondary cardiovascular endpoints are shown in Figure 2.
Rezultati primarnega sestavljenega dogodka in sekundarnih srčno-žilnih opazovanih dogodkov so prikazani na sliki 2.
• Attach the needle, see step 4a
• pritrditi iglo, glejte korak 4a
If you have an injection site reaction (redness, rash, or itching) you may like to ask your doctor for something to help relieve any signs or symptoms.
Če se pojavi reakcija na mestu injiciranja (rdečina, izpuščaj ali srbečica), lahko zdravnika prosite za zdravilo, ki bo pomagalo ublažiti znake in simptome.
If you still cannot push the button in, this may mean that the needle is clogged.
Če gumba še vedno ne morete potisniti noter, to lahko pomeni, da je igla zamašena.
Name and address of the manufacturers responsible for batch release AstraZeneca AB
Ime in naslov izdelovalcev, odgovornih za sproščanje serij AstraZeneca AB
Do not try to unlock with excessive force or tools.
Peresnika ne poskušajte odkleniti s prekomerno silo ali z orodji.
C. Check the mix.
C. Preverite mešanico.
The absolute change in 2-hour postprandial plasma glucose at Week 28 is modeled similarly using ANCOVA.
Absolutna sprememba postprandialne koncentracije glukoze v plazmi 2 uri po obroku po 28 tednih je modelirana podobno z uporabo ANCOVA.
Not known (frequency cannot be estimated from the available data) In addition some other side effects have been reported
Neznana pogostnost (pogostnosti iz razpoložljivih podatkov ni mogoče oceniti) Poleg tega so poročali o nekaterih drugih neželenih učinkih:
Clean the area with an alcohol swab.
Očistite predel z alkoholnim zložencem.
Gently clean the area with soap and water or an alcohol swab.
Predel previdno očistite z milom in vodo ali z alkoholnim zložencem.
You can also change your chosen injection day, as long as your last dose was given 3 or more days before.
Dan za injekcijo lahko tudi spremenite pod pogojem, da ste zadnji odmerek uporabili pred 3 dnevi ali več.
Make a note that you have taken your Bydureon today and mark your calendar for when you are due for your next injection.
Označite si, da ste danes že vzeli zdravilo Bydureon in na koledarju označite, kdaj je vaša naslednja injekcija.
The pen contains an integrated needle.
Peresnik ima integrirano iglo.
Frequencies reported in pooled data from the controlled periods of the two phase 3 clinical studies (n = 410).
Pogostnosti, poročane v združenih podatkih iz kontroliranih obdobij dveh kliničnih študij 3. faze (n = 410).
No predetermined dose adjustment is required; however, lipid profiles should be monitored as appropriate.
Vnaprejšnja prilagoditev odmerkov ni potrebna, zato pa je potrebno ustrezno nadzorovati lipidni profil.
Figure 1: Time to First Adjudicated MACE (intent to treat patients)
Slika 1: Čas do prvega presojenega dogodka MACE (bolniki z-namenom-zdravljenja)
These clumps could clog the needle when you take the injection (see question 7).
Te grudice lahko med injiciranjem zamašijo iglo (glejte 7. vprašanje).
1a Take a single-dose kit from the refrigerator.
1a Enoodmerni set vzemite iz hladilnika.
Patients with an Event (%)
Bolniki z dogodkom (%)
Prolonged-release exenatide should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.
Eksenatida v obliki s podaljšanim sproščanjem ne smemo uporabljati pri bolnikih z diabetesom mellitusom tipa 1 ali za zdravljenje diabetične ketoacidoze.
You do not see it before, during, or after using the pen.
Ne boste je videli niti pred uporabo peresnika, niti med uporabo ali po uporabi.
NOT Mixed Well
Ni dobro premešano
Detailed information on this medicine is available on the website of the European Medicines Agency http://www.ema.europa.eu/
Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila http://www.ema.europa.eu/
Prolonged-release exenatide can be administered at any time of day, with or without meals.
Eksenatid v obliki s podaljšanim sproščanjem se lahko uporabi kadarkoli tekom dneva, s hrano ali brez nje.
If you feel you should stop using this medicine, please consult your doctor first.
Če menite, da bi morali prenehati uporabljati to zdravilo, se o tem najprej posvetujte z zdravnikom.
Do not recycle the container with used pens.
Vsebnika z uporabljenimi peresniki ne reciklirajte.
Prolonged-release exenatide has minor influence on the ability to drive and use machines.
Eksenatid v obliki s podaljšanim sproščanjem ima blag vpliv na sposobnost vožnje in upravljanja strojev.
Figure 2: Forest Plot: Analysis of Primary and Secondary Endpoints (intent to treat patients)
Slika 2: Drevesni diagram: Analiza primarnih in sekundarnih opazovanih dogodkov (bolniki z-namenom-zdravljenja)
Nonclinical studies have shown that exenatide is predominantly eliminated by glomerular filtration with subsequent proteolytic degradation.
Predklinične študije so pokazale, da se eksenatid izloča pretežno z glomerulno filtracijo z nadaljnjo proteolitično razgradnjo.
To prevent losing medicine, do not push in the plunger while attaching the needle.
Da preprečite izgubo zdravila, med pritrjevanjem igle ne pritiskajte na bat.
The effect on HbA1c remained clinically significant over 52 weeks but partially diminished over time in the group that had initially received Bydureon BCise.
Vpliv na HbA1c je ostal klinično pomemben do 52. tedna, a se je sčasoma delno zmanjšal v skupini, ki je uvodoma prejemala zdravilo Bydureon BCise.
You can re-mix your medicine if your pen is in the locked position.
Zdravilo lahko znova premešate, če je peresnik v zaklenjenem položaju.
DO NOT push the injection button yet.
Gumba za injiciranje še NE PRITISNITE.
After the suspension is fully mixed, the preparation steps must be completed immediately and the suspension injected subcutaneously.
Ko je suspenzija popolnoma premešana, je treba korake za pripravo opraviti nemudoma in suspenzijo injicirati subkutano.
Do not use Bydureon: - If you are allergic to exenatide or any of the other ingredients of this medicine (listed in section
Ne uporabljajte zdravila Bydureon - Če ste alergični na eksenatid ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
Also be sure you twisted the knob until it stopped, the orange label disappeared, and the injection button appears.
Prav tako se prepričajte, da ste zasukali gumb, dokler se ne ustavi, oranžna nalepka izgine in se pojavi gumb za injiciranje.
Exenatide Placebo
eksenatid placebo
2 Connecting the parts 3 Mixing the medicine and filling the syringe 4 Injecting the medicine
2 Povezovanje sestavnih delov 3 Mešanje zdravila in polnjenje injekcijske brizge 4 Injiciranje zdravila
This is what the broken-off cap looks like.
Tako izgleda odlomljen pokrovček.
Tap the vial several times against a hard surface to loosen the powder.
Z vialo nekajkrat potrkajte ob trdno površino, da razrahljate prašek.
Paediatric population Interaction studies with exenatide have only been performed in adults.
Pediatrična populacija Študije medsebojnega delovanja z eksenatidom so izvedli le pri odraslih.
What if the device malfunctions and I cannot remove the orange cap?
Kaj, če pripomoček ne deluje pravilno in ne morem odstraniti oranžnega pokrovčka?
It is an injectable medicine used to improve blood sugar control in adults with type 2 diabetes mellitus.
To je zdravilo za injiciranje, ki ga uporabljamo za izboljšanje nadzora sladkorja v krvi pri odraslih s sladkorno boleznijo tipa 2.
Keep shaking until the liquid and powder are mixed well.
S stresanjem nadaljujte, dokler nista tekočina in prašek dobro zmešana.
What Bydureon is and what it is used for
Kaj je zdravilo Bydureon in za kaj ga uporabljamo
Examination of antibody-positive specimens revealed no significant cross-reactivity with similar endogenous peptides (glucagon or GLP-1).
Preiskava vzorcev s pozitivnimi protitelesi ni pokazala značilne navzkrižne reaktivnosti s podobnimi endogenimi peptidi (glukagon ali GLP-1).
Then, take your thumb off the plunger.
Nato palec odstranite iz bata.
Using too much of this medicine can cause nausea, vomiting, dizziness, or symptoms of low blood sugar (see section 4).
Če uporabite preveč tega zdravila, to lahko povzroči slabost (siljenje na bruhanje), bruhanje, omotico ali simptome nizkega krvnega sladkorja (glejte poglavje 4).
The mean HbA1c was 8.1%.
Povprečni HbA1c je bil 8,1 %.
The day of weekly administration can be changed if necessary as long as the last dose was administered at least three days before.
Dan tedenske uporabe se po potrebi lahko zamenja, pri čemer pa mora biti zadnji odmerek uporabljen vsaj tri dni prej.
- If you have type 1 diabetes or diabetic ketoacidosis, as this medicine should not be used.
- Če imate sladkorno bolezen tipa 1 ali diabetično ketoacidozo, ker v tem primeru tega zdravila ne smete uporabljati.
The patient does not need to save any part of the single-use kit.
Bolniku ni treba prihraniti nobenega dela seta za enkratno uporabo.
The medicine is mixed well when the liquid looks cloudy from both sides of the window.
Zdravilo je dobro premešano, ko je tekočina motna na obeh straneh okenca.
After I mix the medicine, how long can I wait before taking the injection?
Koliko časa lahko po premešanju zdravila počakam, preden dam injekcijo?
There is little experience with this medicine in patients with kidney problems.
S tem zdravilom je malo izkušenj pri bolnikih, ki imajo težave z ledvicami.